Analyst Coverage

Analyst Coverage

WeedMD Inc. is followed by the analyst(s) listed below. Please note that any opinions, estimates or forecasts regarding WeedMD Inc. made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of WeedMD  Inc. or its management or Directors. WeedMD Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 

AnalystFirmEmailPhone
Graeme KreindleEight Capitalgkreindler@viiicapital.com 1 (416) 350-5065
Neal GilmerHaywood Securities Inc.ngilmer@haywood.com1 (416) 507-2759
Greg McLeishMackie Research Capital Corp.GMcLeish@mackieresearch.com 1 (416) 860-8633

WELCOME

Are you the age of majority in your province?
(19+, or 18+ in Alberta and Quebec)

   

By entering our site you are agreeing to our
Terms of Use and Privacy Policy.

Safety precautions amidst COVID-19


To help ensure our patients are up to date with all procedures and measures being taken during this time, we have created a website specific to WeedMD and COVID-19 updates.

VISIT PAGE NOW
CLOSE


Our Medical Cannabis Offering is Expanding

X

We have exciting news for WeedMD patients!

Our patients will soon have access to a diverse new medical cannabis offering, featuring familiar WeedMD products as well as new strains, formats and services. This includes access to vapes, same day shipping, a Client Care Team available 7 days a week, and lots more.

Get started below or view our FAQ to learn more about our new one world of medical cannabis services.

Let’s Get Started
View the FAQ